89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 158 filers reported holding 89BIO INC in Q2 2023. The put-call ratio across all filers is 2.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $66,494,522 | -24.4% | 4,306,640 | -7.2% | 0.00% | -20.0% |
Q2 2023 | $87,988,469 | +88.2% | 4,643,191 | +51.2% | 0.01% | +66.7% |
Q1 2023 | $46,761,796 | +1649.0% | 3,070,374 | +1361.9% | 0.00% | – |
Q4 2022 | $2,673,554 | +634.5% | 210,020 | +233.8% | 0.00% | – |
Q3 2022 | $364,000 | +267.7% | 62,910 | +104.2% | 0.00% | – |
Q2 2022 | $99,000 | -82.3% | 30,810 | -79.3% | 0.00% | – |
Q1 2022 | $560,000 | -70.8% | 148,630 | +1.2% | 0.00% | – |
Q4 2021 | $1,919,000 | -33.6% | 146,824 | -0.4% | 0.00% | – |
Q3 2021 | $2,888,000 | +4.1% | 147,403 | -0.6% | 0.00% | – |
Q2 2021 | $2,774,000 | -3.8% | 148,328 | +21.8% | 0.00% | – |
Q1 2021 | $2,883,000 | -2.8% | 121,748 | +0.1% | 0.00% | – |
Q4 2020 | $2,965,000 | +37.7% | 121,672 | +44.9% | 0.00% | – |
Q3 2020 | $2,154,000 | +108.5% | 83,960 | +62.0% | 0.00% | – |
Q2 2020 | $1,033,000 | -14.9% | 51,834 | +7.8% | 0.00% | – |
Q1 2020 | $1,214,000 | +121.1% | 48,086 | +130.5% | 0.00% | – |
Q4 2019 | $549,000 | – | 20,864 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 11,416,948 | $176,277,677 | 3.47% |
Orchard Capital Management, LLC | 542,879 | $8,382,052 | 3.10% |
Artia Global Partners LP | 465,465 | $7,186,780 | 2.99% |
Octagon Capital Advisors LP | 1,219,157 | $18,823,784 | 2.89% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,694,404 | $41,601,598 | 2.25% |
University of Wisconsin Foundation | 126,516 | $1,953,407 | 2.24% |
Tri Locum Partners LP | 249,571 | $3,853,376 | 1.23% |
Endurant Capital Management LP | 82,153 | $1,268,442 | 1.14% |
Parkman Healthcare Partners LLC | 363,553 | $5,613,258 | 1.03% |
ACUTA CAPITAL PARTNERS, LLC | 1,000 | $1,523,000 | 1.02% |